Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05954702
Other study ID # NP 1683
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 21, 2023
Est. completion date October 2026

Study information

Verified date June 2023
Source Instituto do Cancer do Estado de São Paulo
Contact Flavio Takeda, PhD, MD
Phone +55 11 999079973
Email flavio.takeda@hc.fm.usp.br
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Esophagectomy has high rates of morbidity and mortality, in many cases due to esophagus reconstruction. Anastomotic leakage and fistula are the main esophagectomy complications. Many studies underwent to investigate the cause for anastomotic leakage after esophagectomy, however none of them conclude it is related to surgery or suture technique. However, it seems to be triggered by the ischemia caused after stomach mobilization to esophagus reconstruction, or even tension in the anastomosis. Considering the post esophagectomy with gastroplasty high morbidity and mortality rates, strategies to create a new vascularization source and decrease anastomotic leakage rates is important. In this study researchers will evaluate whether a TRAM flap transfer supercharged is effective on decrease morbidity related to anastomosis ischemia in patients undergoing esophagectomy.


Description:

The transfer of muscle parts is one of the main reconstruction techniques used in plastic surgery. Transverse rectus abdominis myocutaneous (TRAM) flap transfers are very considered due to high quality results, wide application in many cases, and small number of reviews in long term. Beegle, in 1991 published a new technique of using TRAM supercharged in which microsurgical anastomosis are used between TRAM's unipedicled gastroepiploic deep artery and veins and thoracic branches and vessels, such as axillary and thoracodorsal vessels. Looking for recover tissue blood perfusion and decrease morbidity rates associated with anastomosis ischemia, some studies showed large intestine or jejunum interposition plus an additional blood supply through venous and arterial anastomosis - colon or jejunum supercharged is effective. The isoperistaltic supercharged colon interposition was a good option to rebuild big esophagus parts in which stomach was not available. Considering the post esophagectomy with gastroplasty high morbidity and mortality rates, strategies to create a new vascularization source and decrease anastomotic leakage rates is important. This is a single-institution, randomized clinical trial with participants recruited in the digestive system surgery clinic, at the Instituto do Câncer do Estado de São Paulo (ICESP). Patients will be randomized to conventional esophagectomy or TRAM supercharged esophagectomy, and researchers will evaluate post-operatory complications in both groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date October 2026
Est. primary completion date July 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosis of esophageal malignancy cancer; - Ability to understand and collaborate during treatment; Exclusion Criteria: - Previous gastrectomy; - Previous abdominal surgery with risk of altering stomach vascularization; - Previous head and neck surgery with risk of alteration of cervical vessels.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Supercharged TRAM esophagectomy
Esophagectomy, immediately followed by supercharged esophagogastroplasty. Use the transverse rectus abdominis myocutaneous (TRAM) flap transfers to surgically create a new anastomosis in the left gastroepiploic vessels.
Conventional Esophagectomy
Esophagectomy, immediately followed by an esophagus reconstruction trough esophagogastroplasty.

Locations

Country Name City State
Brazil Instituto do Cancer do Estado de São Paulo (ICESP) São Paulo SP

Sponsors (1)

Lead Sponsor Collaborator
Instituto do Cancer do Estado de São Paulo

Country where clinical trial is conducted

Brazil, 

References & Publications (46)

Akiyama H, Miyazono H, Tsurumaru M, Hashimoto C, Kawamura T. Use of the stomach as an esophageal substitute. Ann Surg. 1978 Nov;188(5):606-10. doi: 10.1097/00000658-197811000-00004. — View Citation

Akiyama H. Surgery for carcinoma of the esophagus. Curr Probl Surg. 1980 Feb;17(2):53-120. doi: 10.1016/s0011-3840(80)80025-6. No abstract available. — View Citation

Barzin A, Norton JA, Whyte R, Lee GK. Supercharged jejunum flap for total esophageal reconstruction: single-surgeon 3-year experience and outcomes analysis. Plast Reconstr Surg. 2011 Jan;127(1):173-180. doi: 10.1097/PRS.0b013e3181f95a36. — View Citation

Bourke MJ, Hope RL, Chu G, Gillespie PE, Bull C, O'Rourke I, Williams SJ. Laser palliation of inoperable malignant dysphagia: initial and at death. Gastrointest Endosc. 1996 Jan;43(1):29-32. doi: 10.1016/s0016-5107(96)70256-0. — View Citation

Briel JW, Tamhankar AP, Hagen JA, DeMeester SR, Johansson J, Choustoulakis E, Peters JH, Bremner CG, DeMeester TR. Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg. 2004 Apr;198(4):536-41; discussion 541-2. doi: 10.1016/j.jamcollsurg.2003.11.026. — View Citation

Buskens CJ, Hulscher JB, Fockens P, Obertop H, van Lanschot JJ. Benign tracheo-neo-esophageal fistulas after subtotal esophagectomy. Ann Thorac Surg. 2001 Jul;72(1):221-4. doi: 10.1016/s0003-4975(01)02701-1. — View Citation

Collard JM, Tinton N, Malaise J, Romagnoli R, Otte JB, Kestens PJ. Esophageal replacement: gastric tube or whole stomach? Ann Thorac Surg. 1995 Aug;60(2):261-6; discussion 267. doi: 10.1016/0003-4975(95)00411-d. — View Citation

D'Amico TA, Harpole DH Jr. Molecular biology of esophageal cancer. Chest Surg Clin N Am. 2000 Aug;10(3):451-69. — View Citation

Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015 Jul 14;21(26):7933-43. doi: 10.3748/wjg.v21.i26.7933. — View Citation

Edsander-Nord A, Jurell G, Wickman M. Donor-site morbidity after pedicled or free TRAM flap surgery: a prospective and objective study. Plast Reconstr Surg. 1998 Oct;102(5):1508-16. doi: 10.1097/00006534-199810000-00025. — View Citation

El-Mrakby HH, Milner RH, McLean NR. Supercharged pedicled TRAM flap in breast reconstruction: is it a worthwhile procedure. Ann Plast Surg. 2002 Sep;49(3):252-7. doi: 10.1097/00000637-200209000-00003. — View Citation

Ferguson A, Kingstone K. Coeliac disease and malignancies. Acta Paediatr Suppl. 1996 May;412:78-81. doi: 10.1111/j.1651-2227.1996.tb14259.x. — View Citation

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9. — View Citation

Garcia-Vasquez C, Fernandez-Acenero MJ, Garcia Gomez-Heras S, Pastor C. Fibrin patch influences the expression of hypoxia-inducible factor-1alpha and nuclear factor-kappaBp65 factors on ischemic intestinal anastomosis. Exp Biol Med (Maywood). 2018 Jun;243(10):803-808. doi: 10.1177/1535370218777216. — View Citation

GARLOCK JH. Combined abdominothoracic approach for carcinoma of cardia and lower esophagus. Surg Gynecol Obstet. 1946 Dec;83(6):737-41. No abstract available. — View Citation

GARLOCK JH. Resection of thoracic esophagus for carcinoma located above arch of aorta; cervical esophagogastrostomy. Surgery. 1948 Jul;24(1):1-8. No abstract available. — View Citation

Garvey PB, Buchel EW, Pockaj BA, Casey WJ 3rd, Gray RJ, Hernandez JL, Samson TD. DIEP and pedicled TRAM flaps: a comparison of outcomes. Plast Reconstr Surg. 2006 May;117(6):1711-9; discussion 1720-1. doi: 10.1097/01.prs.0000210679.77449.7d. — View Citation

Goffi FS, Bevilacqua RG, Ferreira EA, Silva PA, Pinheiro Y, Lima EW, Bastos Eda S. [Surgery of cancer of he esophagus. Technic and results]. AMB Rev Assoc Med Bras. 1969 Jan;15(1):37-42. No abstract available. Portuguese. — View Citation

Griffin SM, Lamb PJ, Dresner SM, Richardson DL, Hayes N. Diagnosis and management of a mediastinal leak following radical oesophagectomy. Br J Surg. 2001 Oct;88(10):1346-51. doi: 10.1046/j.0007-1323.2001.01918.x. — View Citation

Grotting JC, Beckenstein MS, Arkoulakis NS. The art and science of autologous breast reconstruction. Breast J. 2003 Sep-Oct;9(5):350-60. doi: 10.1046/j.1524-4741.2003.09527.x. — View Citation

Harashina T, Sone K, Inoue T, Fukuzumi S, Enomoto K. Augmentation of circulation of pedicled transverse rectus abdominis musculocutaneous flaps by microvascular surgery. Br J Plast Surg. 1987 Jul;40(4):367-70. doi: 10.1016/0007-1226(87)90039-7. — View Citation

Hermreck AS, Crawford DG. The esophageal anastomotic leak. Am J Surg. 1976 Dec;132(6):794-8. doi: 10.1016/0002-9610(76)90461-x. — View Citation

Holmstrom H. The free abdominoplasty flap and its use in breast reconstruction. An experimental study and clinical case report. Scand J Plast Reconstr Surg. 1979;13(3):423-27. doi: 10.3109/02844317909013092. — View Citation

Kassis ES, Kosinski AS, Ross P Jr, Koppes KE, Donahue JM, Daniel VC. Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg. 2013 Dec;96(6):1919-26. doi: 10.1016/j.athoracsur.2013.07.119. Epub 2013 Sep 24. — View Citation

Kesler KA, Pillai ST, Birdas TJ, Rieger KM, Okereke IC, Ceppa D, Socas J, Starnes SL. "Supercharged" isoperistaltic colon interposition for long-segment esophageal reconstruction. Ann Thorac Surg. 2013 Apr;95(4):1162-8; discussion 1168-9. doi: 10.1016/j.athoracsur.2013.01.006. Epub 2013 Feb 21. — View Citation

Kim EK, Lee TJ, Eom JS. Comparison of fat necrosis between zone II and zone III in pedicled transverse rectus abdominis musculocutaneous flaps: a prospective study of 400 consecutive cases. Ann Plast Surg. 2007 Sep;59(3):256-9. doi: 10.1097/01.sap.0000252770.15946.14. — View Citation

Kim SH, Lee KS, Shim YM, Kim K, Yang PS, Kim TS. Esophageal resection: indications, techniques, and radiologic assessment. Radiographics. 2001 Sep-Oct;21(5):1119-37; discussion 1138-40. doi: 10.1148/radiographics.21.5.g01se031119. — View Citation

Koop H. Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy. 2004 Feb;36(2):103-9. doi: 10.1055/s-2004-814177. — View Citation

Kroll SS. Bilateral breast reconstruction in very thin patients with extended free TRAM flaps. Br J Plast Surg. 1998 Oct;51(7):535-7. doi: 10.1054/bjps.1998.0014. — View Citation

Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999 Mar 18;340(11):825-31. doi: 10.1056/NEJM199903183401101. — View Citation

Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999 Jun 1;130(11):883-90. doi: 10.7326/0003-4819-130-11-199906010-00003. — View Citation

Liebermann-Meffert DM, Meier R, Siewert JR. Vascular anatomy of the gastric tube used for esophageal reconstruction. Ann Thorac Surg. 1992 Dec;54(6):1110-5. doi: 10.1016/0003-4975(92)90077-h. — View Citation

LONGMIRE WP Jr. A modification of the Roux technique for antethoracic esophageal reconstruction. Surgery. 1947 Jul;22(1):94-100. No abstract available. — View Citation

Marck KW, van der Biezen JJ, Dol JA. Internal mammary artery and vein supercharge in TRAM flap breast reconstruction. Microsurgery. 1996;17(7):371-4. doi: 10.1002/(SICI)1098-2752(1996)17:73.0.CO;2-J. — View Citation

Molina-Navarro C, Hosking SW, Hayward SJ, Flowerdew AD. Gastroaortic fistula as an early complication of esophagectomy. Ann Thorac Surg. 2001 Nov;72(5):1783-8. doi: 10.1016/s0003-4975(00)02569-8. — View Citation

Morris SF, Taylor GI. Predicting the survival of experimental skin flaps with a knowledge of the vascular architecture. Plast Reconstr Surg. 1993 Dec;92(7):1352-61. — View Citation

NAKAYAMA K. Statistical review of five-year survivals after surgery for carcinoma of the esophagus and cardiac portion of the stomach. Surgery. 1959 Jun;45(6):883-9. No abstract available. — View Citation

Pernia LR, Miller HL, Saltz R, Vasconez LO. "Supercharging" the rectus abdominis muscle to provide a single flap for cover of large mediastinal wound defects. Br J Plast Surg. 1991 May-Jun;44(4):243-6. doi: 10.1016/0007-1226(91)90064-q. — View Citation

Rezai M, Darsow M, Kummel S, Kramer S. Autologous and alloplastic breast reconstruction--overview of techniques, indications and results. Gynakol Geburtshilfliche Rundsch. 2008;48(2):68-75. doi: 10.1159/000118934. Epub 2008 Apr 16. — View Citation

Scheflan M, Hartrampf CR, Black PW. Breast reconstruction with a transverse abdominal island flap. Plast Reconstr Surg. 1982 May;69(5):908-9. No abstract available. — View Citation

Serletti JM. Breast reconstruction with the TRAM flap: pedicled and free. J Surg Oncol. 2006 Nov 1;94(6):532-7. doi: 10.1002/jso.20492. — View Citation

Urschel JD. Ischemic conditioning of the stomach may reduce the incidence of esophagogastric anastomotic leaks complicating esophagectomy: a hypothesis. Dis Esophagus. 1997 Jul;10(3):217-9. doi: 10.1093/dote/10.3.217. — View Citation

Valverde A, Hay JM, Fingerhut A, Elhadad A. Manual versus mechanical esophagogastric anastomosis after resection for carcinoma: a controlled trial. French Associations for Surgical Research. Surgery. 1996 Sep;120(3):476-83. doi: 10.1016/s0039-6060(96)80066-3. — View Citation

van Lanschot JJ, Hulscher JB, Buskens CJ, Tilanus HW, ten Kate FJ, Obertop H. Hospital volume and hospital mortality for esophagectomy. Cancer. 2001 Apr 15;91(8):1574-8. doi: 10.1002/1097-0142(20010415)91:83.0.co;2-2. — View Citation

Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001 Mar;233(3):338-44. doi: 10.1097/00000658-200103000-00006. — View Citation

Yamamoto Y, Nohira K, Sugihara T, Shintomi Y, Ohura T. Superiority of the microvascularly augmented flap: analysis of 50 transverse rectus abdominis myocutaneous flaps for breast reconstruction. Plast Reconstr Surg. 1996 Jan;97(1):79-83; discussion 84-5. doi: 10.1097/00006534-199601000-00013. — View Citation

* Note: There are 46 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Presence and number of post-operatory complications surgical wound infection, hematoma, anastomotic leakage, stenosis, chylothorax and clinical complications due to hospitalization Until 1 year after Surgery
Primary Mortality Patients who and when died Until 1 year after surgery after surgery
Secondary Days in intensive care unit Number of days patient will stay at intensive care unit From the surgery day until the date patient leave intensive care unit
Secondary Hospitalization period Number of days patient will stay in hospital after surgery From the surgery day until the date patient leave hospital
Secondary Need of vasoactive drugs If patient use vasoactive drugs drugs hospitalization From the surgery day until the date patient leave hospital
Secondary Blood transfusion need If patients need blood transfusion during hospitalization From the surgery day until the date patient leave hospital
Secondary Drain use time How long patient use drain From the surgery day until the date patient took off drain
See also
  Status Clinical Trial Phase
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Completed NCT00201747 - Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer Phase 2
Recruiting NCT06036563 - Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Not yet recruiting NCT05023928 - Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus Cancer Phase 1
Recruiting NCT03941626 - Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies Phase 1/Phase 2
Recruiting NCT04907643 - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes N/A
Recruiting NCT02988921 - MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy N/A
Completed NCT02979691 - Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01 Phase 2/Phase 3
Terminated NCT02797405 - Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay N/A
Recruiting NCT03347630 - Pre-operative MRI of Esophagus Cancer N/A
Completed NCT00193141 - Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer Phase 2
Recruiting NCT05626309 - Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer N/A
Completed NCT05615129 - Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting
Recruiting NCT04821765 - Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer Phase 2
Terminated NCT03108885 - Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Recruiting NCT04046575 - Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer Phase 1
Recruiting NCT06126406 - Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors Phase 1
Completed NCT03467529 - Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study
Completed NCT02552121 - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors Phase 1/Phase 2
Completed NCT02001623 - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors Phase 1/Phase 2